Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Other Working Capital Changes (2017 - 2023)

Celcuity's (CELC) quarterly Other Working Capital Changes came in at -$7.7 million in Q4 2025, down 649.17% YoY from $1.4 million in Q4 2024, and down 241.48% on a QoQ basis from $5.4 million in Q3 2025.

Analysis

Celcuity (CELC) Other Working Capital Changes (2017 - 2023) Analysis & Trends

Celcuity (CELC) has 9 years of Other Working Capital Changes data on file, last reported at -$7.7 million in Q4 2025.

  • Quarterly Other Working Capital Changes fell 649.17% year-over-year to -$7.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 207.98% YoY) and the FY2025 annual result came in at $3.0 million, up 207.98% from the prior year.
  • Other Working Capital Changes retreated to -$7.7 million in Q4 2025, from $5.4 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $5.4 million in Q3 2025 to a low of -$7.7 million in Q4 2025.
  • A 5-year average of $479551.8 and a median of $99006.0 in 2021 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 1801.56% — and 2025, when it jumped 2118.15%.
  • Tracing CELC's Other Working Capital Changes over 5 years: stood at $285326.0 in 2021, then sank by 202.11% to -$291356.0 in 2022, then soared by 914.22% to $2.4 million in 2023, then slumped by 143.38% to -$1.0 million in 2024, then tumbled by 649.17% to -$7.7 million in 2025.
  • The last three Other Working Capital Changes figures came in at -$7.7 million (Q4 2025), $5.4 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Celcuity 5.25 Bn 5.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -64,212.00
Jun 30, 2023 -64,212.00
Mar 31, 2023 181,211.00
Mar 31, 2023 181,211.00
Dec 31, 2022 -234,095.00
Dec 31, 2022 -234,095.00
Sep 30, 2022 1.98 Mn
Sep 30, 2022 1.98 Mn
Jun 30, 2022 3.84 Mn
Jun 30, 2022 3.84 Mn
Mar 31, 2022 40,205.00
Mar 31, 2022 40,205.00
Dec 31, 2021 285,326.00
Dec 31, 2021 285,326.00
Sep 30, 2021 157,807.00
Sep 30, 2021 157,807.00
Jun 30, 2021 -271,801.00
Jun 30, 2021 -271,801.00
Mar 31, 2021 234,305.00
Mar 31, 2021 234,305.00